Genetic variant in XPD Lys751Gln had been demonstrated to be associated with some cancers risk in different meta-analysis, such as esophageal cancer, gastric cancer, colorectal cancer, breast cancer, prostate cancer, lung cancer and bladder cancer [14]–[23]. This evidence concerns the gene ERCC2 and breast cancer.